{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:35:40Z","timestamp":1789263340850,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00403-018-1823-y","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T12:23:04Z","timestamp":1519906984000},"page":"383-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["IL-17 inhibition: is it the long-awaited savior for alopecia areata?"],"prefix":"10.1007","volume":"310","author":[{"given":"Yuval","family":"Ramot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Marzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Sorbellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"key":"1823_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","volume":"148","author":"B Afzali","year":"2007","unstructured":"Afzali B, Lombardi G, Lechler RI et al (2007) The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148:32\u201346","journal-title":"Clin Exp Immunol"},{"key":"1823_CR2","doi-asserted-by":"publisher","first-page":"304370","DOI":"10.1155\/2014\/304370","volume":"2014","author":"S Aghaei","year":"2014","unstructured":"Aghaei S, Saki N, Daneshmand E et al. (2014) Prevalence of psychological disorders in patients with alopecia areata in comparison with normal subjects. ISRN Dermatol 2014: 304370","journal-title":"ISRN Dermatol"},{"key":"1823_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1529-8019.2011.01419.x","volume":"24","author":"A Alkhalifah","year":"2011","unstructured":"Alkhalifah A (2011) Topical and intralesional therapies for alopecia areata. Dermatol Ther 24:355\u2013363","journal-title":"Dermatol Ther"},{"key":"1823_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","volume":"62","author":"A Alkhalifah","year":"2010","unstructured":"Alkhalifah A, Alsantali A, Wang E et al (2010) Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 62:177\u2013188, quiz 189\u2013190","journal-title":"J Am Acad Dermatol"},{"key":"1823_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","volume":"62","author":"A Alkhalifah","year":"2010","unstructured":"Alkhalifah A, Alsantali A, Wang E et al (2010) Alopecia areata update: part II. Treatment. J Am Acad Dermatol 62:191\u2013202, quiz 203\u2013194","journal-title":"J Am Acad Dermatol"},{"key":"1823_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4049\/jimmunol.1100657","volume":"188","author":"R Alli","year":"2012","unstructured":"Alli R, Nguyen P, Boyd K et al (2012) A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis. J Immunol 188:477\u2013486","journal-title":"J Immunol"},{"key":"1823_CR7","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/eji.201242653","volume":"42","author":"A Ambrosi","year":"2012","unstructured":"Ambrosi A, Espinosa A, Wahren-Herlenius M (2012) IL-17: a new actor in IFN-driven systemic autoimmune diseases. Eur J Immunol 42:2274\u20132284","journal-title":"Eur J Immunol"},{"key":"1823_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000445182","volume":"8","author":"F Anzengruber","year":"2016","unstructured":"Anzengruber F, Maul JT, Kamarachev J et al (2016) Transient efficacy of tofacitinib in alopecia areata universalis. Case Rep Dermatol 8:102\u2013106","journal-title":"Case Rep Dermatol"},{"key":"1823_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1155\/MI.2005.273","volume":"2005","author":"O Arican","year":"2005","unstructured":"Arican O, Aral M, Sasmaz S et al. (2005) Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005: 273\u2013279","journal-title":"Mediators Inflamm"},{"key":"1823_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.clim.2012.12.004","volume":"146","author":"ME Ariza","year":"2013","unstructured":"Ariza ME, Williams MV, Wong HK (2013) Targeting IL-17 in psoriasis: from cutaneous immunobiology to clinical application. Clin Immunol 146:131\u2013139","journal-title":"Clin Immunol"},{"key":"1823_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/09546630802206686","volume":"19","author":"A Asarch","year":"2008","unstructured":"Asarch A, Barak O, Loo DS et al (2008) Th17 cells: a new paradigm for cutaneous inflammation. J Dermatolog Treat 19:259\u2013266","journal-title":"J Dermatolog Treat"},{"key":"1823_CR12","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/ijd.12808","volume":"55","author":"MA Atwa","year":"2016","unstructured":"Atwa MA, Youssef N, Bayoumy NM (2016) T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-alpha) in patients with alopecia areata: association with clinical type and severity. Int J Dermatol 55:666\u2013672","journal-title":"Int J Dermatol"},{"key":"1823_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/1346-8138.12740","volume":"42","author":"S Avitabile","year":"2015","unstructured":"Avitabile S, Sordi D, Garcovich S et al (2015) Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients. J Dermatol 42:98\u201399","journal-title":"J Dermatol"},{"key":"1823_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1177\/0300060514549784","volume":"43","author":"N Aytekin","year":"2015","unstructured":"Aytekin N, Akcali C, Pehlivan S et al (2015) Investigation of interleukin-12, interleukin-17 and interleukin-23 receptor gene polymorphisms in alopecia areata. J Int Med Res 43:526\u2013534","journal-title":"J Int Med Res"},{"key":"1823_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni0407-345","volume":"8","author":"E Bettelli","year":"2007","unstructured":"Bettelli E, Oukka M, Kuchroo VK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345\u2013350","journal-title":"Nat Immunol"},{"key":"1823_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jdermsci.2015.01.004","volume":"78","author":"R Biran","year":"2015","unstructured":"Biran R, Zlotogorski A, Ramot Y (2015) The genetics of alopecia areata: new approaches, new findings, new treatments. J Dermatol Sci 78:11\u201320","journal-title":"J Dermatol Sci"},{"key":"1823_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ebiom.2015.03.022","volume":"2","author":"U Blume-Peytavi","year":"2015","unstructured":"Blume-Peytavi U, Vogt A (2015) Translational positioning of janus kinase (JAK) inhibitors in alopecia areata. EBioMedicine 2:282\u2013283","journal-title":"EBioMedicine"},{"key":"1823_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/DAD.0b013e318185a66e","volume":"31","author":"ED Cetin","year":"2009","unstructured":"Cetin ED, Savk E, Uslu M et al (2009) Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol 31:53\u201360","journal-title":"Am J Dermatopathol"},{"key":"1823_CR19","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/art.22866","volume":"56","author":"Z Chen","year":"2007","unstructured":"Chen Z, Tato CM, Muul L et al (2007) Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 56:2936\u20132946","journal-title":"Arthritis Rheum"},{"key":"1823_CR20","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jaci.2007.01.010","volume":"119","author":"W Chi","year":"2007","unstructured":"Chi W, Yang P, Li B et al (2007) IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 119:1218\u20131224","journal-title":"J Allergy Clin Immunol"},{"key":"1823_CR21","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/rheumatology\/kev102","volume":"54","author":"F Ciccia","year":"2015","unstructured":"Ciccia F, Rizzo A, Guggino G et al (2015) Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis. Rheumatology 54:1596\u20131604","journal-title":"Rheumatology"},{"key":"1823_CR22","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1038\/jid.2014.260","volume":"134","author":"BG Craiglow","year":"2014","unstructured":"Craiglow BG, King BA (2014) Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis. J Invest Dermatol 134:2988\u20132990","journal-title":"J Invest Dermatol"},{"key":"1823_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri2800","volume":"10","author":"DJ Cua","year":"2010","unstructured":"Cua DJ, Tato CM (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10:479\u2013489","journal-title":"Nat Rev Immunol"},{"key":"1823_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nm.3685","volume":"20","author":"SJ Divito","year":"2014","unstructured":"Divito SJ, Kupper TS (2014) Inhibiting janus kinases to treat alopecia areata. Nat Med 20:989\u2013990","journal-title":"Nat Med"},{"key":"1823_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/jid.2012.344","volume":"133","author":"FJ Duncan","year":"2013","unstructured":"Duncan FJ, Silva KA, Johnson CJ et al (2013) Endogenous retinoids in the pathogenesis of alopecia areata. J Invest Dermatol 133:334\u2013343","journal-title":"J Invest Dermatol"},{"key":"1823_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1529-8019.2011.01414.x","volume":"24","author":"LC Dy","year":"2011","unstructured":"Dy LC, Whiting DA (2011) Histopathology of alopecia areata, acute and chronic: why is it important to the clinician? Dermatol Ther 24:369\u2013374","journal-title":"Dermatol Ther"},{"key":"1823_CR27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/ijd.12994","volume":"55","author":"EH El-Morsy","year":"2016","unstructured":"El-Morsy EH, Eid AA, Ghoneim H et al (2016) Serum level of interleukin-17A in patients with alopecia areata and its relationship to age. Int J Dermatol 55:869\u2013874","journal-title":"Int J Dermatol"},{"key":"1823_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00403-016-1617-z","volume":"308","author":"MA Elela","year":"2016","unstructured":"Elela MA, Gawdat HI, Hegazy RA et al (2016) B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of alopecia areata. Arch Dermatol Res 308:115\u2013121","journal-title":"Arch Dermatol Res"},{"key":"1823_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13555-016-0102-0","volume":"6","author":"B Farahnik","year":"2016","unstructured":"Farahnik B, Beroukhim K, Zhu TH et al (2016) Ixekizumab for the treatment of psoriasis: a review of phase III trials. Dermatol Ther (Heidelb) 6:25\u201337","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1823_CR30","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1038\/jid.2009.88","volume":"129","author":"EL Fitch","year":"2009","unstructured":"Fitch EL, Rizzo HL, Kurtz SE et al (2009) Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23\/Th17 inflammatory pathway. J Invest Dermatol 129:2443\u20132450","journal-title":"J Invest Dermatol"},{"key":"1823_CR31","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","volume":"183","author":"F Fossiez","year":"1996","unstructured":"Fossiez F, Djossou O, Chomarat P et al (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183:2593\u20132603","journal-title":"J Exp Med"},{"key":"1823_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/gut.52.1.65","volume":"52","author":"S Fujino","year":"2003","unstructured":"Fujino S, Andoh A, Bamba S et al (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65\u201370","journal-title":"Gut"},{"key":"1823_CR33","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1111\/jdv.13325","volume":"29","author":"N Garzorz","year":"2015","unstructured":"Garzorz N, Alsisi M, Todorova A et al (2015) Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases. J Eur Acad Dermatol Venereol 29:2429\u20132435","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1823_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","volume":"228","author":"K Ghoreschi","year":"2009","unstructured":"Ghoreschi K, Laurence A, O\u2019Shea JJ (2009) Janus kinases in immune cell signaling. Immunol Rev 228:273\u2013287","journal-title":"Immunol Rev"},{"key":"1823_CR35","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1056\/NEJMra1103442","volume":"366","author":"A Gilhar","year":"2012","unstructured":"Gilhar A, Etzioni A, Paus R (2012) Alopecia areata. N Engl J Med 366:1515\u20131525","journal-title":"N Engl J Med"},{"key":"1823_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.autrev.2005.07.001","volume":"5","author":"A Gilhar","year":"2006","unstructured":"Gilhar A, Kalish RS (2006) Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 5:64\u201369","journal-title":"Autoimmun Rev"},{"key":"1823_CR37","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1172\/JCI31942","volume":"117","author":"A Gilhar","year":"2007","unstructured":"Gilhar A, Paus R, Kalish RS (2007) Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 117:2019\u20132027","journal-title":"J Clin Invest"},{"key":"1823_CR38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1684\/ejd.2013.2042","volume":"23","author":"CN Giordano","year":"2013","unstructured":"Giordano CN, Sinha AA (2013) Cytokine pathways and interactions in alopecia areata. Eur J Dermatol 23:308\u2013318","journal-title":"Eur J Dermatol"},{"key":"1823_CR39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1365-2133.2012.11099.x","volume":"167","author":"G Girolomoni","year":"2012","unstructured":"Girolomoni G, Mrowietz U, Paul C (2012) Psoriasis: rationale for targeting interleukin-17. Br J Dermatol 167:717\u2013724","journal-title":"Br J Dermatol"},{"key":"1823_CR40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.autrev.2013.01.004","volume":"12","author":"A Greco","year":"2013","unstructured":"Greco A, Fusconi M, Gallo A et al (2013) Vogt-Koyanagi-Harada syndrome. Autoimmun Rev 12:1033\u20131038","journal-title":"Autoimmun Rev"},{"key":"1823_CR41","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/jdv.13598","volume":"30","author":"AK Gupta","year":"2016","unstructured":"Gupta AK, Carviel JL, Abramovits W. (2016) Efficacy of tofacitinib in treatment of alopecia universalis in two patients. J Eur Acad Dermatol Venereol 30:1373\u20131378","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1823_CR42","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/1346-8138.12978","volume":"42","author":"YM Han","year":"2015","unstructured":"Han YM, Sheng YY, Xu F et al (2015) Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata. J Dermatol 42:981\u2013988","journal-title":"J Dermatol"},{"key":"1823_CR43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5070\/D32QZ018FC","volume":"15","author":"WM Haque","year":"2009","unstructured":"Haque WM, Mir MR, Hsu S (2009) Vogt-Koyanagi-Harada syndrome: association with alopecia areata. Dermatol Online J 15:10","journal-title":"Dermatol Online J"},{"key":"1823_CR44","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/eji.201242613","volume":"43","author":"I Harpaz","year":"2013","unstructured":"Harpaz I, Abutbul S, Nemirovsky A et al (2013) Chronic exposure to stress predisposes to higher autoimmune susceptibility in C57BL\/6 mice: glucocorticoids as a double-edged sword. Eur J Immunol 43:758\u2013769","journal-title":"Eur J Immunol"},{"key":"1823_CR45","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR et al (2005) Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123\u20131132","journal-title":"Nat Immunol"},{"key":"1823_CR46","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1529-8019.2011.01421.x","volume":"24","author":"MK Hordinsky","year":"2011","unstructured":"Hordinsky MK (2011) Treatment of alopecia areata: \u201cWhat is new on the horizon?\u201d Dermatol Ther 24:364\u2013368","journal-title":"Dermatol Ther"},{"key":"1823_CR47","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.4049\/jimmunol.167.11.6225","volume":"167","author":"B Huard","year":"2001","unstructured":"Huard B, Schneider P, Mauri D et al (2001) T cell costimulation by the TNF ligand BAFF. J Immunol 167:6225\u20136231","journal-title":"J Immunol"},{"key":"1823_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1346-8138.2011.01476.x","volume":"39","author":"T Ito","year":"2012","unstructured":"Ito T (2012) Advances in the management of alopecia areata. J Dermatol 39:11\u201317","journal-title":"J Dermatol"},{"key":"1823_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","volume":"2","author":"A Jabbari","year":"2015","unstructured":"Jabbari A, Dai Z, Xing L et al (2015) Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib. EBioMedicine 2:351\u2013355","journal-title":"EBioMedicine"},{"key":"1823_CR50","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/exd.13060","volume":"25","author":"A Jabbari","year":"2016","unstructured":"Jabbari A, Nguyen N, Cerise JE et al (2016) Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers. Exp Dermatol 25:642\u2013643","journal-title":"Exp Dermatol"},{"key":"1823_CR51","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.4049\/jimmunol.167.8.4430","volume":"167","author":"M Kawaguchi","year":"2001","unstructured":"Kawaguchi M, Onuchic LF, Li XD et al (2001) Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol 167:4430\u20134435","journal-title":"J Immunol"},{"key":"1823_CR52","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jaci.2005.12.1346","volume":"117","author":"M Kawaguchi","year":"2006","unstructured":"Kawaguchi M, Takahashi D, Hizawa N et al (2006) IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol 117:795\u2013801","journal-title":"J Allergy Clin Immunol"},{"key":"1823_CR53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1755-148X.2011.00945.x","volume":"25","author":"Y Kotobuki","year":"2012","unstructured":"Kotobuki Y, Tanemura A, Yang L et al (2012) Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris. Pigment Cell Melanoma Res 25:219\u2013230","journal-title":"Pigment Cell Melanoma Res"},{"key":"1823_CR54","doi-asserted-by":"publisher","first-page":"313","DOI":"10.7888\/juoeh.33.313","volume":"33","author":"R Kubo","year":"2011","unstructured":"Kubo R, Nakamura M, Tokura Y (2011) Alopecia universalis following two sequential traffic accidents: possible association with increased Th1 and Th17 cells and decreased Th2 cells. J UOEH 33:313\u2013317","journal-title":"J UOEH"},{"key":"1823_CR55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/0974-7753.66920","volume":"2","author":"M Kumaresan","year":"2010","unstructured":"Kumaresan M (2010) Intralesional steroids for alopecia areata. Int J Trichol 2:63\u201365","journal-title":"Int J Trichol"},{"key":"1823_CR56","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jdermsci.2008.01.004","volume":"50","author":"Y Kuwano","year":"2008","unstructured":"Kuwano Y, Fujimoto M, Watanabe R et al (2008) Serum BAFF and APRIL levels in patients with alopecia areata. J Dermatol Sci 50:236\u2013239","journal-title":"J Dermatol Sci"},{"key":"1823_CR57","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.4049\/jimmunol.162.4.2347","volume":"162","author":"M Laan","year":"1999","unstructured":"Laan M, Cui ZH, Hoshino H et al (1999) Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162:2347\u20132352","journal-title":"J Immunol"},{"key":"1823_CR58","doi-asserted-by":"publisher","first-page":"14993","DOI":"10.1073\/pnas.0806044105","volume":"105","author":"Q Lai Kwan Lam","year":"2008","unstructured":"Lai Kwan Lam Q, King Hung Ko O, Zheng BJ et al (2008) Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci USA 105:14993\u201314998","journal-title":"Proc Natl Acad Sci USA"},{"key":"1823_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5021\/ad.2012.24.1.61","volume":"24","author":"BL Lew","year":"2012","unstructured":"Lew BL, Cho HR, Haw S et al (2012) Association between IL17A\/IL17RA gene polymorphisms and susceptibility to alopecia areata in the Korean population. Ann Dermatol 24:61\u201365","journal-title":"Ann Dermatol"},{"key":"1823_CR60","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","volume":"203","author":"SC Liang","year":"2006","unstructured":"Liang SC, Tan XY, Luxenberg DP et al (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271\u20132279","journal-title":"J Exp Med"},{"key":"1823_CR61","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/art.20001","volume":"50","author":"E Lubberts","year":"2004","unstructured":"Lubberts E, Koenders MI, Oppers-Walgreen B et al (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650\u2013659","journal-title":"Arthritis Rheum"},{"key":"1823_CR62","doi-asserted-by":"publisher","first-page":"e400-405","DOI":"10.1111\/j.1468-3083.2011.04351.x","volume":"27","author":"NM Luk","year":"2013","unstructured":"Luk NM, Chiu LS, Lee KC et al (2013) Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata. J Eur Acad Dermatol Venereol 27:e400-405","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1823_CR63","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan PR, Harrington LE, O\u2019Quinn DB et al (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231\u2013234","journal-title":"Nature"},{"key":"1823_CR64","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4049\/jimmunol.175.1.404","volume":"175","author":"F McAllister","year":"2005","unstructured":"McAllister F, Henry A, Kreindler JL et al (2005) Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 175:404\u2013412","journal-title":"J Immunol"},{"key":"1823_CR65","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.0022-202X.2005.23692.x","volume":"124","author":"KJ McElwee","year":"2005","unstructured":"McElwee KJ, Freyschmidt-Paul P, Hoffmann R et al (2005) Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)\/CD25(\u2013) cells promote systemic alopecia areata and CD4(+)\/CD25(+) cells blockade disease onset in the C3H\/HeJ mouse model. J Invest Dermatol 124:947\u2013957","journal-title":"J Invest Dermatol"},{"key":"1823_CR66","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/exd.12209","volume":"22","author":"KJ McElwee","year":"2013","unstructured":"McElwee KJ, Gilhar A, Tobin DJ et al (2013) What causes alopecia areata? Exp Dermatol 22:609\u2013626","journal-title":"Exp Dermatol"},{"key":"1823_CR67","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000063371","volume":"204","author":"Y Miyazaki","year":"2002","unstructured":"Miyazaki Y, Yamamoto T, Watanabe K et al (2002) Alopecia universalis associated with Zumbusch-type generalized pustular psoriasis. Dermatology 204:308\u2013309","journal-title":"Dermatology"},{"key":"1823_CR68","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2332\/allergolint.11-OA-0303","volume":"60","author":"T Narita","year":"2011","unstructured":"Narita T, Oiso N, Fukai K et al (2011) Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergol Int 60:505\u2013508","journal-title":"Allergol Int"},{"key":"1823_CR69","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0065-2776(08)00605-6","volume":"99","author":"DB O\u2019Quinn","year":"2008","unstructured":"O\u2019Quinn DB, Palmer MT, Lee YK et al (2008) Emergence of the Th17 pathway and its role in host defense. Adv Immunol 99:115\u2013163","journal-title":"Adv Immunol"},{"key":"1823_CR70","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1346-8138.2011.01438.x","volume":"39","author":"N Oiso","year":"2012","unstructured":"Oiso N, Kawada A (2012) Renbok phenomenon in a patient with alopecia areata universalis and psoriasis. J Dermatol 39:288\u2013289","journal-title":"J Dermatol"},{"key":"1823_CR71","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","volume":"28","author":"W Ouyang","year":"2008","unstructured":"Ouyang W, Kolls JK, Zheng Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28:454\u2013467","journal-title":"Immunity"},{"key":"1823_CR72","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/0974-7753.130397","volume":"5","author":"Y Ovcharenko","year":"2013","unstructured":"Ovcharenko Y, Serbina I, Zlotogorski A et al (2013) Renbok phenomenon in an alopecia areata patient with psoriasis. Int J Trichology 5:194\u2013195","journal-title":"Int J Trichology"},{"key":"1823_CR73","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133\u20131141","journal-title":"Nat Immunol"},{"key":"1823_CR74","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/jid.2009.111","volume":"129","author":"R Paus","year":"2009","unstructured":"Paus R, Arck P (2009) Neuroendocrine perspectives in alopecia areata: does stress play a role? J Invest Dermatol 129:1324\u20131326","journal-title":"J Invest Dermatol"},{"key":"1823_CR75","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature09114","volume":"466","author":"L Petukhova","year":"2010","unstructured":"Petukhova L, Duvic M, Hordinsky M et al (2010) Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466:113\u2013117","journal-title":"Nature"},{"key":"1823_CR76","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1176\/appi.psy.44.5.374","volume":"44","author":"A Picardi","year":"2003","unstructured":"Picardi A, Pasquini P, Cattaruzza MS et al (2003) Psychosomatic factors in first-onset alopecia areata. Psychosomatics 44:374\u2013381","journal-title":"Psychosomatics"},{"key":"1823_CR77","doi-asserted-by":"publisher","first-page":"17011","DOI":"10.1038\/nrdp.2017.11","volume":"3","author":"CH Pratt","year":"2017","unstructured":"Pratt CH, King LE Jr, Messenger AG et al (2017) Alopecia areata. Nat Rev Dis Primers 3:17011","journal-title":"Nat Rev Dis Primers"},{"key":"1823_CR78","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0014-2999(03)01341-4","volume":"462","author":"O Prause","year":"2003","unstructured":"Prause O, Laan M, Lotvall J et al (2003) Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 462:193\u2013198","journal-title":"Eur J Pharmacol"},{"key":"1823_CR79","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/0974-7753.77522","volume":"2","author":"Y Ramot","year":"2010","unstructured":"Ramot Y, Thomaidou E, Mali A et al (2010) An extraordinary colocalization of alopecia areata and vitiligo. Int J Trichology 2:108\u2013109","journal-title":"Int J Trichology"},{"key":"1823_CR80","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000369408","volume":"47","author":"Y Ramot","year":"2015","unstructured":"Ramot Y, Zlotogorski A (2015) Molecular genetics of alopecias. Curr Probl Dermatol 47:87\u201396","journal-title":"Curr Probl Dermatol"},{"key":"1823_CR81","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s12325-017-0542-7","volume":"34","author":"Y Renert-Yuval","year":"2017","unstructured":"Renert-Yuval Y, Guttman-Yassky E (2017) The changing landscape of alopecia areata: the therapeutic paradigm. Adv Ther 34:1594\u20131609","journal-title":"Adv Ther"},{"key":"1823_CR82","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/14712598.2016.1188076","volume":"16","author":"Y Renert-Yuval","year":"2016","unstructured":"Renert-Yuval Y, Guttman-Yassky E (2016) A novel therapeutic paradigm for patients with extensive alopecia areata. Expert Opin Biol Ther 16:1005\u20131014","journal-title":"Expert Opin Biol Ther"},{"key":"1823_CR83","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/eji.201545910","volume":"46","author":"B Schminke","year":"2016","unstructured":"Schminke B, Trautmann S, Mai B et al (2016) Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage. Eur J Immunol 46:440\u2013445","journal-title":"Eur J Immunol"},{"key":"1823_CR84","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/1346-8138.12369","volume":"41","author":"A Shimizu","year":"2014","unstructured":"Shimizu A, Kamiyama Y, Kato M et al (2014) Alopecia in a patient with Vogt-Koyanagi-Harada disease. J Dermatol 41:184\u2013185","journal-title":"J Dermatol"},{"key":"1823_CR85","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jaad.2015.09.045","volume":"74","author":"R Shreberk-Hassidim","year":"2016","unstructured":"Shreberk-Hassidim R, Ramot Y, Gilula Z et al (2016) A systematic review of pulse steroid therapy for alopecia areata. J Am Acad Dermatol 74:372\u2013374 e371-375","journal-title":"J Am Acad Dermatol"},{"key":"1823_CR86","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jaad.2016.12.004","volume":"76","author":"R Shreberk-Hassidim","year":"2017","unstructured":"Shreberk-Hassidim R, Ramot Y, Zlotogorski A (2017) Janus kinase inhibitors in dermatology: a systematic review. J Am Acad Dermatol 76:745\u2013753 e719","journal-title":"J Am Acad Dermatol"},{"key":"1823_CR87","doi-asserted-by":"publisher","first-page":"e0147979","DOI":"10.1371\/journal.pone.0147979","volume":"11","author":"SH Smith","year":"2016","unstructured":"Smith SH, Peredo CE, Takeda Y et al (2016) Development of a topical treatment for psoriasis targeting RORgamma: from bench to skin. PLoS One 11:e0147979","journal-title":"PLoS One"},{"key":"1823_CR88","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/bjd.14703","volume":"175","author":"R Speeckaert","year":"2016","unstructured":"Speeckaert R, Lambert J, Grine L et al. (2016) The many faces of IL-17 in inflammatory skin diseases. Br J Dermatol 175:893\u2013901","journal-title":"Br J Dermatol"},{"key":"1823_CR89","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","volume":"136","author":"M Suarez-Farinas","year":"2015","unstructured":"Suarez-Farinas M, Ungar B, Noda S et al (2015) Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing. J Allergy Clin Immunol 136:1277\u20131287","journal-title":"J Allergy Clin Immunol"},{"key":"1823_CR90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/08923973.2013.862542","volume":"36","author":"J Sun","year":"2014","unstructured":"Sun J, Dou W, Zhao Y et al (2014) A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model. Immunopharmacol Immunotoxicol 36:17\u201324","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1823_CR91","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1346-8138.2011.01462.x","volume":"39","author":"R Takei-Taniguchi","year":"2012","unstructured":"Takei-Taniguchi R, Imai Y, Ishikawa C et al (2012) Interleukin-17- and protease-activated receptor 2-mediated production of CXCL1 and CXCL8 modulated by cyclosporine A, vitamin D3 and glucocorticoids in human keratinocytes. J Dermatol 39:625\u2013631","journal-title":"J Dermatol"},{"key":"1823_CR92","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jdermsci.2012.06.010","volume":"67","author":"A Tanemura","year":"2012","unstructured":"Tanemura A, Kotobuki Y, Itoi S et al (2012) Positive link between STAT3 activation and Th17 cell infiltration to the lesional skin in vitiligo vulgaris. J Dermatol Sci 67:207\u2013209","journal-title":"J Dermatol Sci"},{"key":"1823_CR93","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000350933","volume":"226","author":"A Tanemura","year":"2013","unstructured":"Tanemura A, Oiso N, Nakano M et al (2013) Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles. Dermatology 226:333\u2013336","journal-title":"Dermatology"},{"key":"1823_CR94","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/bjd.12396","volume":"169","author":"MK Tembhre","year":"2013","unstructured":"Tembhre MK, Sharma VK (2013) T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata. Br J Dermatol 169:543\u2013548","journal-title":"Br J Dermatol"},{"key":"1823_CR95","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000353159","volume":"227","author":"G Tojo","year":"2013","unstructured":"Tojo G, Fujimura T, Kawano M et al (2013) Comparison of interleukin-17-producing cells in different clinical types of alopecia areata. Dermatology 227:78\u201382","journal-title":"Dermatology"},{"key":"1823_CR96","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8620-9","author":"RM Tr\u00fceb","year":"2017","unstructured":"Tr\u00fceb RM, Dias M (2017) Alopecia areata: a comprehensive review of pathogenesis and management. Clin Rev Allergy Immunol. https:\/\/doi.org\/10.1007\/s12016-017-8620-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"1823_CR97","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.semarthrit.2013.04.006","volume":"43","author":"WB Berg van den","year":"2013","unstructured":"van den Berg WB, McInnes IB (2013) Th17 cells and IL-17 a\u2013focus on immunopathogenesis and immunotherapeutics. Semin Arthritis Rheum 43:158\u2013170","journal-title":"Semin Arthritis Rheum"},{"key":"1823_CR98","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s12325-017-0540-9","volume":"34","author":"ECE Wang","year":"2017","unstructured":"Wang ECE, Christiano AM (2017) The Changing landscape of alopecia areata: the translational landscape. Adv Ther 34:1586\u20131593","journal-title":"Adv Ther"},{"key":"1823_CR99","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1365-4632.2007.03193.x","volume":"46","author":"D Wasserman","year":"2007","unstructured":"Wasserman D, Guzman-Sanchez DA, Scott K et al (2007) Alopecia areata. Int J Dermatol 46:121\u2013131","journal-title":"Int J Dermatol"},{"key":"1823_CR100","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","volume":"24","author":"CT Weaver","year":"2006","unstructured":"Weaver CT, Harrington LE, Mangan PR et al (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677\u2013688","journal-title":"Immunity"},{"key":"1823_CR101","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ni1497","volume":"8","author":"NJ Wilson","year":"2007","unstructured":"Wilson NJ, Boniface K, Chan JR et al (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8:950\u2013957","journal-title":"Nat Immunol"},{"key":"1823_CR102","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/imm.12552","volume":"147","author":"AC Wing","year":"2016","unstructured":"Wing AC, Hygino J, Ferreira TB et al (2016) Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients. Immunology 147:212\u2013220","journal-title":"Immunology"},{"key":"1823_CR103","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clim.2008.01.019","volume":"127","author":"CK Wong","year":"2008","unstructured":"Wong CK, Lit LC, Tam LS et al (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 127:385\u2013393","journal-title":"Clin Immunol"},{"key":"1823_CR104","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.3645","volume":"20","author":"L Xing","year":"2014","unstructured":"Xing L, Dai Z, Jabbari A et al (2014) Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med 20:1043\u20131049","journal-title":"Nat Med"},{"key":"1823_CR105","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1346-8138.1995.tb03886.x","volume":"22","author":"T Yamamoto","year":"1995","unstructured":"Yamamoto T, Watanabe K, Katayama I et al (1995) Alopecia universalis in a patient with psoriasis vulgaris. J Dermatol 22:623\u2013624","journal-title":"J Dermatol"},{"key":"1823_CR106","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","volume":"3","author":"Z Yao","year":"1995","unstructured":"Yao Z, Fanslow WC, Seldin MF et al (1995) Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3:811\u2013821","journal-title":"Immunity"},{"key":"1823_CR107","doi-asserted-by":"publisher","first-page":"e0117704","DOI":"10.1371\/journal.pone.0117704","volume":"10","author":"X Ye","year":"2015","unstructured":"Ye X, Zhang L, Wang H et al (2015) The role of IL-23\/Th17 pathway in patients with primary immune thrombocytopenia. PLoS One 10:e0117704","journal-title":"PLoS One"},{"key":"1823_CR108","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI21404","volume":"116","author":"D Yen","year":"2006","unstructured":"Yen D, Cheung J, Scheerens H et al (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310\u20131316","journal-title":"J Clin Invest"},{"key":"1823_CR109","doi-asserted-by":"publisher","first-page":"e93754","DOI":"10.1371\/journal.pone.0093754","volume":"9","author":"N Zhang","year":"2014","unstructured":"Zhang N, Van Crombruggen K, Holtappels G et al (2014) Suppression of cytokine release by fluticasone furoate vs. mometasone furoate in human nasal tissue ex-vivo. PLoS One 9:e93754","journal-title":"PLoS One"},{"key":"1823_CR110","doi-asserted-by":"publisher","first-page":"e23629","DOI":"10.1371\/journal.pone.0023629","volume":"6","author":"X Zhou","year":"2011","unstructured":"Zhou X, Xia Z, Lan Q et al (2011) BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis. PLoS One 6:e23629","journal-title":"PLoS One"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-018-1823-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1823-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1823-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T10:53:41Z","timestamp":1693565621000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-018-1823-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1007\/s00403-018-1823-y","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,1]]},"assertion":[{"value":"11 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Barbara Marzani and Daniela Pinto are employed by Giuliani S.p.A. Fabio Rinaldi has served in a consultancy function for Giuliani S.p.A. Yuval Ramot has received travel support from Giuliani S.p.A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}